Subcellular localization of PP5 TFPI-2 in human placenta: A possible role of PP5 TFPI-2 as an anti-coagulant on the surface of syncytiotrophoblasts

Placenta

Volumn 23, Issue 2-3, 2002, Pages 145-153

  Udagawa, K ^a   Yasumitsu, H ^a   Esaki, M ^a   Sawada, H ^a   Nagashima, Y ^a   Aoki, I ^a   Jin, M ^a   Miyagi, E ^a   Nakazawa, T ^a   Hirahara, F ^a   Miyazaki, K ^a   Miyagi, Y ^b  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

^b KANAGAWA CANCER CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRIN; GLYPICAN; HEPARIN; MESSENGER RNA; PLACENTA PROTEIN 5; POLYCLONAL ANTIBODY; PP5 ANTIBODY; PROTEOGLYCAN; SYNDECAN; UNCLASSIFIED DRUG; GLYCOPROTEIN; PLACENTA PROTEIN; TISSUE-FACTOR-PATHWAY INHIBITOR 2;

ARTICLE; BLOOD CLOTTING; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; ENZYME INHIBITION; FEMALE; FETOPLACENTAL UNIT; FIBRIN DEPOSITION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOELECTRON MICROSCOPY; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MEMBRANE BINDING; MICROVILLUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PLACENTA; PLACENTA CIRCULATION; PLACENTA DEVELOPMENT; PLACENTA VILLUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SYNCYTIOTROPHOBLAST; WESTERN BLOTTING; ADULT; CHORION VILLUS; CYTOLOGY; DRUG EFFECT; GESTATIONAL AGE; METABOLISM; PHYSIOLOGY; TROPHOBLAST; ULTRASTRUCTURE;

ADULT; BLOOD COAGULATION; CHORIONIC VILLI; ENDOPLASMIC RETICULUM; FEMALE; GESTATIONAL AGE; GLYCOPROTEINS; HEPARIN; HUMANS; IMMUNOHISTOCHEMISTRY; MICROSCOPY, IMMUNOELECTRON; MICROVILLI; PREGNANCY PROTEINS; TROPHOBLASTS;

EID: 0036483023     PISSN: 01434004     EISSN: None     Source Type: Journal    
DOI: 10.1053/plac.2001.0774     Document Type: Article

References (32)

1. Ameri A, Kuppuswamy MN, Basu S & Bajaj SP (1992) Expression of tissue factor pathway inhibitor by cultured endothelial cells in response to inflammatory mediators. Blood, 79, 3219-3226.
2. Andreasen PA, Kjoller L, Christensen L & Duffy MJ (1997) The urokinase-type plasminogen activator system in cancer metastasis: a review. Int J Cancer, 72, 1-22.
3. Bajaj MS, Kuppuswamy MN, Saito H, Spitzer SG & Bajaj SP (1990) Cultured normal human hepatocytes do not synthesize lipoprotein-associated coagulation inhibitor: evidence that endothelium is the principal site of its synthesis. Proc Natl Acad Sci USA, 87, 8869-8873.
4. Bohn H & Winckler W (1977) Isolation and characterization of the placental protein pp5. Arch Gynakol, 223, 179-186.
5. Broze GJ Jr & Miletich JP (1987) Isolation of the tissue factor inhibitor produced by HepG2 hepatoma cells. Proc Natl Acad Sci USA, 84, 1886-1890.
6. Butzow R, Virtanen I, Seppala M, Narvanen O, Stenman UH, Ristimaki A & Bohn H (1988) Monoclonal antibodies reacting with placental protein 5: use in radioimmunoassay, Western blot analysis, and immunohistochemistry. J Lab Clin Med, 111, 249-256.
7. DeClerck YA, Imren S, Montgomery AM, Mueller BM, Reisfeld RA & Laug WE (1997) Proteases and protease inhibitors in tumor progression. Adv Exp Med Biol, 425, 89-97.
8. Edstrom CS, Calhoun DA & Christensen RD (2000) Expression of tissue factor pathway inhibitor in human fetal and placental tissues. Early Hum Dev, 59, 77-84.
9. Hansen JB, Olsen R & Webster P (1997) Association of tissue factor pathway inhibitor with human umbilical vein endothelial cells. Blood, 90, 3568-3578.
10. Iino M, Foster DC & Kisiel W (1998) Quantification and characterization of human endothelial cell-derived tissue factor pathway inhibitor-2. Arterioscler Thromb Vasc Biol, 18, 40-46.
11. Kario K, Matsuo T, Yamada T & Matsuo M (1994). Increased tissue factor pathway inhibitor levels in uremic patients on regular hemodialysis. Thromb Haemost, 71, 275-279.
12. Koshikawa N, Nakamura T, Tsuchiya N, Isaji M, Yasumitsu H, Umeda M & Miyazaki K (1996) Purification and identification of a novel and four known serine proteinase inhibitors secreted by human glioblastoma cells. J Biochem (Tokyo), 119, 334-339.
13. Liotta LA & Stetler-Stevenson WG (1991) Tumor invasion and metastasis: an imbalance of positive and negative regulation. Cancer Res, 51, 5054s-5059s.
14. Mast AE, Higuchi DA, Huang ZF, Warshawsky I, Schwartz AL & Broze GJ Jr (1997) Glypican-3 is a binding protein on the HepG2 cell surface for tissue factor pathway inhibitor. Biochem J, 327, 577-583.
15. Menabawey M, Silman R, Rice A & Chard T (1985) Dramatic increase of placental protein 5 levels following injection of small doses of heparin. Br J Obstet Gynaecol, 92, 207-210.
16. Miyagi Y, Koshikawa N, Yasumitsu H, Miyagi E, Hirahara F, Aoki I, Misugi K, Umeda M & Miyazaki K (1994) cDNA cloning and mRNA expression of a serine proteinase inhibitor secreted by cancer cells: identification as placental protein 5 and tissue factor pathway inhibitor-2. J Biochem (Tokyo), 116, 939-942.
17. Nagashima Y, Hasegawa S, Koshikawa N, Taki A, Ichikawa Y, Kitamura H, Misugi K, Kihira Y, Matuo Y, Yasumitsu H & Miyazaki K (1997) Expression of matrilysin in vascular endothelial cells adjacent to matrilysin-producing tumors. Int J Cancer, 72, 441-445.
18. Nisbet AD, Bremner RD, Herriot R, Jandial V, Horne CH & Bohn H (1981) Placental protein 5 (PP5): development of a radioimmunoassay and measurement of circulating levels in normal pregnancy. Br J Obstet Gynaecol, 88, 484-491.
19. Petersen LC, Bjorn SE, Olsen OH, Nordfang O, Norris F & Norris K (1996) Inhibitory properties of separate recombinant Kunitz-type-protease- inhibitor domains from tissue-factor-pathway inhibitor. Eur J Biochem, 235, 310-316.
20. Rao CN, Gomez DE, & Woodley DT & Thorgeirsson UP (1995) Partial characterization of novel serine proteinase inhibitors from human umbilical vein endothelial cells. Arch Biochem Biophys, 319, 55-62.
21. Rao CN, Reddy P, Liu Y, O'Toole E, Reeder D, Foster DC, Kisiel W, & Woodley DT (1996) Extracellular matrix-associated serine protease inhibitors (Mr 33,000, 31,000, and 27,000) are single-gene products with differential glycosylation: cDNA cloning of the 33-kDa inhibitor reveals its identity to tissue factor pathway inhibitor-2. Arch Biochem Biophys, 335, 82-92.
22. Sandset PM, Abildgaard U & Larsen ML (1988) Heparin induces release of extrinsic coagulation pathway inhibitor (EPI). Thromb Res, 50, 803-813.
23. Sato H, Okada Y & Seiki M (1997) Membrane-type matrix metalloproteinases (MT-MMPs) in cell invasion. Thromb Haemost, 78, 497-500.
24. Sawada H & Esaki M (1994) Use of nanogold followed by silver enhancement and gold toning for preembedding immunolocalization in osmium-fixed, Epon-embedded tissues. J Electron Microsc (Tokyo), 43, 361-366.
25. Seppala M, Wahlstrom T & Bohn H (1979) Circulating levels and tissue localization of placental protein five (PP5) in pregnancy and trophoblastic disease: absence of PP5 expression in the malignant trophoblast. Int J Cancer, 24, 6-10.
26. Spicer EK, Horton R, Bloem L, Bach R, Williams KR, Guha A, Kraus J, Lin TC, Nemerson Y & Konigsberg WH (1987) Isolation of cDNA clones coding for human tissue factor: primary structure of the protein and cDNA. Proc Natl Acad Sci USA, 84, 5148-5152.
27. Sprecher CA, Kisiel W, Mathewes S & Foster DC (1994) Molecular cloning, expression, and partial characterization of a second human tissue-factor-pathway inhibitor. Proc Natl Acad Sci USA, 91, 3353-3357.
28. Udagawa K, Miyagi Y, Hirahara F, Miyagi E, Nagashima Y, Minaguchi H, Misugi K, Yasumitsu H & Miyazaki K (1998) Specific expression of PP5/TFPI2 mRNA by syncytiotrophoblasts in human placenta as revealed by in situ hybridization. Placenta, 19, 217-223.
29. Werling RW, Zacharski LR, Kisiel W, Bajaj SP, Memoli VA & Rousseau SM (1993) Distribution of tissue factor pathway inhibitor in normal and malignant human tissues. Thromb Haemost, 69, 366-369.
30. Woessner JF Jr (1991) Matrix metalloproteinases and their inhibitors in connective tissue remodeling. Faseb J, 5, 2145-2154.
31. Wun TC, Kretzmer KK, Girard TJ, Miletich JP & Broze GJ Jr (1988) Cloning and characterization of a cDNA coding for the lipoprotein-associated coagulation inhibitor shows that it consists of three tandem Kunitz-type inhibitory domains. J Biol Chem, 263, 6001-6004.
32. Yamabe H, Osawa H, Inuma H, Kaizuka M, Tamura N, Tsunoda S, Fujita Y, Shirato K & Onodera K (1996) Tissue factor pathway inhibitor production by human mesangial cells in culture. Thromb Haemost, 76, 215-219.